UNSPSC 51102817: Amphotericin b/tetracycline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM900. This VA Drug Class (AM900) classifies this compound as belonging to the group ANTI-INFECTIVES, OTHER.

UNSPSC 51102817 Amphotericin b/tetracycline is a Commodity code that does not align with the recent state and local contract opportunities posted under it. The four opportunities on record span naloxone and drug deactivation systems procurement (Seminole County, Florida), direct-to-manufacturer pharmacy prescription programs (Texas HHS Commission), medical and first aid supplies for emergency response (City of Tampa), and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations explicitly target amphotericin B or tetracycline antibiotics, suggesting either misclassification at posting or a significant divergence between the code's nominal pharmaceutical scope and the work state and local governments are actually buying under it.

The issuing bodies across recent postings reflect a mix of county health departments, state health agencies, municipal fire departments, and cooperative purchasing alliances spanning Florida, Texas, and Minnesota. The most recent activity includes Seminole County's competitive bid for naloxone and drug deactivation systems (due July 26, 2023—significantly dated relative to the June 30, 2026 posting date), the Texas HHS Commission's Request for Information on direct-to-manufacturer prescriptions (due April 3, 2026), the City of Tampa's sealed bid for medical and first aid supplies designated as a Small Local Business Enterprise sheltered market with a $700,000 estimated contract value (due March 13, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's Request for Proposal for generic pharmaceuticals and OTC products through authorized wholesalers with proposals due March 26, 2026. The code shows little relevant recent activity targeting the antibiotic commodities its name suggests; business development professionals should verify whether this code remains active for amphotericin B and tetracycline procurement or whether state and local buyers have migrated to alternative classification schemes for antibiotic sourcing.